OncLive SOSS

Evolving Approaches in the Management of Neuroendocrine Tumor-Associated Carcinoid Syndrome - Episode 2

Overview of Carcinoid Syndrome (CS)

September 13, 2022

Satya (Nanu) Das, MD, MSCI, Jerome Zacks, MD, Rodney Pommier, MD

Rodney Pommier, MD, defines carcinoid syndrome and describes the process of diagnosis and clinical risk factors in patients.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

EP. 1: Overview of Neuroendocrine Tumors (NETs)

EP. 2: Overview of Carcinoid Syndrome (CS)

EP. 3: Overview of Carcinoid Heart Disease (CHD)

EP. 4: Management of Carcinoid Syndrome-Related Symptoms

EP. 5: Diagnosis and Management of Somatostatin Analog-Refractory Carcinoid Syndrome

EP. 6: Available Treatment Options for Somatostatin Analog-Refractory Carcinoid Syndrome

EP. 7: Data from the TELEPATH Trial and Real-World Analyses

EP. 8: Prevention, Treatment, and Management of Carcinoid Heart Disease

EP. 9: Unmet Needs for Patients with Neuroendocrine Tumor-Associated Carcinoid Syndrome

EP. 10: Advice for Community Physicians Treating Patients with Neuroendocrine Tumor-Associated Carcinoid Syndrome

x